Cargando…
ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer
Cancers are heterogeneous by nature. While traditional oncology screens commonly use a single endpoint of cell viability, altering the phenotype of tumor-initiating cells may reveal alternative targets that regulate cellular growth by processes other than apoptosis or cell division. We evaluated the...
Autores principales: | Strietz, Juliane, Stepputtis, Stella S., Preca, Bogdan-Tiberius, Vannier, Corinne, Kim, Mihee M., Castro, David J., Au, Qingyan, Boerries, Melanie, Busch, Hauke, Aza-Blanc, Pedro, Heynen-Genel, Susanne, Bronsert, Peter, Kuster, Bernhard, Stickeler, Elmar, Brabletz, Thomas, Oshima, Robert G., Maurer, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347769/ https://www.ncbi.nlm.nih.gov/pubmed/27829216 http://dx.doi.org/10.18632/oncotarget.13086 |
Ejemplares similares
-
Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity
por: Strietz, Juliane, et al.
Publicado: (2021) -
The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors
por: Mock, Kerstin, et al.
Publicado: (2015) -
Chemotherapeutic Stress Influences Epithelial–Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer
por: Li, Xiao, et al.
Publicado: (2020) -
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
por: Preca, Bogdan-Tiberius, et al.
Publicado: (2017) -
In vitro kinase assay reveals ADP-heptose-dependent ALPK1 autophosphorylation and altered kinase activity of disease-associated ALPK1 mutants
por: García-Weber, Diego, et al.
Publicado: (2023)